Jump to Navigation
Trends and Sentiments
Comments and Analysis
Colombians jailed in Venezuela for $15 grocery run
Russia-Ukraine gas deal keeps Europe warm
Watch this 3-D scanner-printer fail
Foreign fighters not deterred by air strikes against ISIS...
Greenspan: Fed on 'a pile of tinder'
Cashin: Rally isn't what you think
Legal woes continue to stalk Swiss banks
Retailers Are Launching Black Friday Sales the Day After...
Budweiser profits pinched by Russia
Goodbye QE, hello new Fed bias
Emisphere: Crown Jewel In Oral B12
Analyzing Wednesday's Noteworthy Insider Buys And Sells
7 Healthcare Stocks With January Catalysts
Analyzing Friday's Noteworthy Insider Buys And Sells
Novel Cancer Treatment Gains Acceptance
Targeted Chemotherapy: The Perfect Balance Between Safety And Efficacy?
Hyper-Novel Investments For Targeting Cancer
Notable Micro Cap Insider Buys Last Week
Biotechnology And Drug Stocks Up For FDA Approval In August
Delcath Systems 's CEO Discusses Q2 2012 Results - Earnings Call Transcript
Cancer Treatment Need Is The Mother Of Novel Solutions
Delcath Systems: An Exclusive Interview With ROTH Capital Senior Analyst
Interview: Delcath's CEO Provides Details About The Resubmission Of The FDA's New Drug Application For CHEMOSAT
Delcath Systems: A Frustrating Stock With Quite A Bit Of Value Potential
Biotech Weekend Recap: Bears, Bears Everywhere
Delcath Systems Management Discusses Q3 2012 Results - Earnings Call Transcript
Delcath Systems' CEO Presents at Lazard Capital Markets 9th Annual Healthcare Conference (Transcript)
Q3 2012 Pharma Company Updates Indicate Upcoming Catalysts
Three Reasons Delcath Systems Appears Undervalued
Is Delcath The Post-Celsion Play On Liver Cancer?
Cancer Radiation Stocks To Consider: Delcath, Spectrum And IsoRay
The Business Of Cancer
Delcath Systems: 'Improving The Bicycle' In Chemotherapy
Delcath Systems: Bullish On Melblez FDA Panel Vote And Subsequent Approval
Canada’s war on ISIS begins — but no orders come...
Justin Bourque handed harshest sentence since...
EUR/GBP: 1.2761 USD/EUR: 1.2533 JPY/USD: 112.1585
Bullfax.com - Market News & Analysis 2008-2011
Terms & Conditions